Monte Rosa Therapeutics, Inc. (GLUE) Deferred Tax Assets, Valuation Allowance USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Monte Rosa Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2020 to 2023.
  • Monte Rosa Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $54.5 M, a 64.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $54.5 M +$21.4 M +64.6% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $33.1 M +$15.3 M +86.1% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $17.8 M +$11.7 M +194% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $6.04 M Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.